Adjuvant Rituximab - a potential cure for the young patient with Graves' hyperthyroidism.

Drake, Amanda (Principal Investigator)

Deanery of Clinical Sciences

Status	Finished
Effective start/end date	1/03/16 → 30/06/20

Funding

MRC: £38,754.00

2 Article

Adjuvant Rituximab – exploratory trial in young people with Graves’ disease
Cheetham, T., Cole, M., Abinun, M., Allahabadia, A., Barratt, T., Davies, J. H., Dimitri, P., Drake, A., Mohamed, Z., Murray, R. D., Steele, C., Zammitt, N., Carnell, S., Prichard, J., Watson, G., Hambleton, S., Matthews, J. N. S. & Pearce, S. H. S., 23 Oct 2021, In: The Journal of Clinical Endocrinology & Metabolism (JCEM).
Research output: Contribution to journal › Article › peer-review

Open Access
File
Adjuvant Rituximab, a potential treatment for the young patient with Graves’ hyperthyroidism (RiGD): study protocol for a single arm, single stage, phase II trial
Cole, M., Hynes, A. M., Howel, D., Hall, L., Abinun, M., Allahabadia, A., Barrett, T., Boelaert, K., Drake, A., Dimitri, P., Kirk, J., Zammitt, N., Pearce, S. & Cheetham, T., 21 Jan 2019, In: BMJ Open.
Research output: Contribution to journal › Article › peer-review

Open Access
File